Chien Tsai-Ju, Liu Chia-Yu, Ko Pin-Hao, Hsu Chung-Hua
Institute of Traditional Medicine, National Yang-Ming University, Taipei, Taiwan Oncology Department, Zhong-Xing Branch, Taipei City Hospital, Taipei, Taiwan.
Institute of Traditional Medicine, National Yang-Ming University, Taipei, Taiwan Chinese Medicine and Lin-Sen Branch, Taipei City Hospital, Taipei, Taiwan.
Integr Cancer Ther. 2016 Mar;15(1):113-23. doi: 10.1177/1534735415617282. Epub 2015 Nov 25.
Kuan-Sin-Yin (KSY) is a traditional Chinese medicine (TCM) decoction, which has been shown to have cytostatic effects on cancer cells and involved in the TCM theory of promoting yin-yang balance.Sonce many cancer patients suffer from autonomic dysfunction (AD), which correspond to yin-yang imbalance in TCM. The aim of this study is to evaluate the possible effect of KSY in metastatic colon cancer (mCRC) patients with AD.
We conducted a single-group experiment. Total 52 qualified patients were enrolled. Participants took the KSY daily for 2 weeks. The primary outcome was KSY efficacy as reflected in the heart rate variability (HRV) and electrical conductivity (µA) over 12 meridian points. Autonomic function was examined before and after the KSY intervention. The vagal and sympathetic tone were recorded by HRV; 12 meridian energies were measured using a meridian energy analysis device. Secondary outcomes were cancer-related symptoms and patient quality of life (QoL).
The results showed that the KSY intervention improved AD via increasing the vagal tone (HF: P = .041), but not the sympathetic tone (LF: P = .154); total autonomic activity was significantly enhanced (HRV activity: P = .013). Intriguingly, energy increased more over the yin meridian (P = .010) than over the yang meridian (P = .015). Cancer-related symptoms and QoL were significantly improved (P < .05).
The safety and effectiveness of KSY in improving AD in mCRC patients are through regulating the vagal-sympathetic dynamic balance, which correspond to the TCM yin-yang concept of energy.
观音饮(KSY)是一种中药汤剂,已被证明对癌细胞具有细胞抑制作用,并涉及中医阴阳平衡理论。由于许多癌症患者患有自主神经功能障碍(AD),这在中医中对应于阴阳失衡。本研究的目的是评估KSY对患有AD的转移性结肠癌(mCRC)患者的可能疗效。
我们进行了一项单组实验。共招募了52名合格患者。参与者每天服用KSY,持续2周。主要结局是KSY的疗效,通过心率变异性(HRV)和12个经络点的电导率(µA)来反映。在KSY干预前后检查自主神经功能。通过HRV记录迷走神经和交感神经张力;使用经络能量分析仪测量12条经络的能量。次要结局是癌症相关症状和患者生活质量(QoL)。
结果表明,KSY干预通过增加迷走神经张力(高频:P = 0.041)改善了AD,但未增加交感神经张力(低频:P = 0.154);总自主神经活动显著增强(HRV活动:P = 0.013)。有趣的是,阴经上的能量增加幅度(P = 0.010)大于阳经(P = 0.015)。癌症相关症状和QoL得到显著改善(P < 0.05)。
KSY在改善mCRC患者AD方面的安全性和有效性是通过调节迷走神经 - 交感神经动态平衡来实现的,这与中医能量的阴阳概念相对应。